Magnesium Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Magnesium dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Magnesium.
Dosing Protocols
Beginner Magnesium Protocol (6-8 weeks):
- Week 1: Magnesium glycinate 100-200 mg elemental once daily at dinner or bedtime. Start low to assess tolerance and any GI effects. Observe for any changes in sleep, stress, muscle tension, bowel regularity.
- Week 2-3: Increase to 200 mg elemental at dinner or bedtime. Most users notice subjective improvement in sleep onset, morning grogginess, or general relaxation within this window.
- Week 4-6: Titrate to 300-400 mg elemental at bedtime, taken as a single dose or split into dinner + bedtime. This is a typical maintenance range for healthy adults seeking general repletion and sleep benefit.
- Week 7-8: Maintain at the dose that produces consistent benefit without loose stool. Consider adding 25 mg P5P (active B6) at breakfast if energy and stress resilience have not improved—some users respond better with B6 support.
Starting form recommendation: magnesium glycinate (bisglycinate) for evening use. Target 200-400 mg elemental total daily. Expect subjective benefits within 1-4 weeks, biomarker changes (blood pressure, fasting glucose in deficient individuals) within 8-12 weeks.
Stack additions to consider:
- Vitamin D 2,000-4,000 IU with breakfast (see /compound/vitamin-d)
- Zinc picolinate 15-30 mg with a meal (see /compound/zinc)
- Omega-3 EPA+DHA 1-2 g with a meal (see /compound/omega-3-fatty-acids)
Cost at this level: approximately $10-15 per month for the magnesium alone.
Intermediate Magnesium Protocol (targeted goals):
For insomnia / poor sleep quality:
- Magnesium glycinate 400 mg elemental at bedtime
- Plus glycine 3 g at bedtime
- Plus optional melatonin 0.3-1 mg at bedtime
- Expect improvement in sleep onset and subjective quality within 1-3 weeks; maintain indefinitely.
For mild-to-moderate hypertension (SBP 130-139 or DBP 80-89):
- Magnesium glycinate 400 mg elemental daily (morning or evening, split if needed)
- Plus taurine 3 g daily
- Plus potassium from dietary sources (fruit, vegetables, beans)
- Monitor home blood pressure morning and evening for 4-8 weeks; expect 2-6 mmHg reduction.
For migraine prophylaxis:
- Magnesium citrate or glycinate 500-600 mg elemental daily (split AM and PM to minimize GI)
- Plus riboflavin (B2) 400 mg daily (separate evidence base)
- Plus CoQ10 100-200 mg daily (separate evidence base)
- Expect meaningful reduction in attack frequency by weeks 8-12; full benefit by 3-4 months. See /compound/coq10.
For prediabetes / insulin resistance / type 2 diabetes (adjunct):
- Magnesium chloride or glycinate 400-500 mg elemental daily
- Plus berberine 500 mg × 3 daily (see /compound/berberine)
- Plus vitamin D if deficient (see /compound/vitamin-d)
- Check fasting insulin/glucose, HbA1c, HOMA-IR at baseline and 12 weeks.
For general longevity / foundational stack:
- Magnesium glycinate 300 mg elemental AM + 200 mg elemental PM
- Plus vitamin D 2,000-4,000 IU with breakfast
- Plus zinc picolinate 15-30 mg with breakfast
- Plus omega-3 EPA+DHA 2 g with dinner
- Plus creatine 5 g daily (any timing)
- Plus optional glycine 5 g at bedtime
Common intermediate forms: glycinate (best general), citrate (lower cost, mild laxative), taurate (cardiovascular), chloride (repletion). Avoid oxide for targeted dosing.
Cost at intermediate level: approximately $25-40 per month for the magnesium + closest stack partners.
Advanced Magnesium Protocol (clinical-condition targeted or cognitive-focused):
For cognitive enhancement / neuroprotection:
- Magnesium L-threonate (Magtein) 1,500-2,000 mg (144-200 mg elemental) split AM and afternoon
- Plus magnesium glycinate 200-300 mg elemental at bedtime (to achieve total-body repletion alongside threonate's brain-specific action)
- Plus phosphatidylcholine or citicoline for cholinergic support
- Plus omega-3 DHA-forward formulation 2-3 g daily
- Plus exercise ≥150 min/week moderate intensity
- Evidence base: Liu et al. for threonate; broad literature for multimodal cognitive support. Expect subtle cognitive changes over 12+ weeks.
For chronic fatigue / fibromyalgia / myalgic encephalomyelitis:
- Magnesium malate 500-1,000 mg (delivering ~80-160 mg elemental) AM with breakfast
- Plus magnesium glycinate 200-300 mg elemental PM
- Plus CoQ10 (ubiquinol) 200 mg daily
- Plus D-ribose 5 g × 2-3 daily (anecdotal)
- Plus addressing vitamin D, B12, iron
- Evidence base modest for each, but the combination addresses multiple plausible mitochondrial and energetic pathways.
For heart failure (adjunctive, under cardiologist supervision only):
- Magnesium orotate 6,000 mg (~400 mg elemental) daily based on Stepura and Martynow- Alternatively magnesium taurate 2-3 g daily
- Plus taurine 3 g daily (Azuma protocol-aligned)
- Plus CoQ10 200-300 mg daily
- Plus guideline-directed medical therapy (ACEi/ARB/ARNI, beta-blocker, MRA, SGLT2i as indicated)
- Monitor renal function and serum magnesium; do not self-prescribe in advanced CKD.
For severe insomnia refractory to standard approach:
- Magnesium glycinate 400-600 mg elemental at bedtime
- Plus magnesium L-threonate 1,000 mg at bedtime (brain penetration for NMDA modulation)
- Plus glycine 5 g at bedtime
- Plus apigenin 50 mg or chamomile extract
- Plus behavioral (CBT-I) approach
- Evaluate for underlying sleep apnea before advanced protocols.
For ADHD / anxiety (adjunctive):
- Magnesium glycinate 400 mg elemental at breakfast
- Plus L-theanine 200-400 mg morning and afternoon (see /compound/l-theanine)
- Plus omega-3 with high EPA
- Plus standard-of-care ADHD/anxiety management
Diagnostic work-up recommended before advanced dosing:
- Serum magnesium (note: may be normal despite deficiency)
- Red blood cell magnesium (more sensitive measure of total-body stores)
- Ionized serum magnesium (research setting)
- Serum 25(OH)D
- Complete metabolic panel (renal function)
- PTH if bone-health or calcium concerns
Advanced users often rotate or combine forms: threonate for cognition, glycinate for sleep, taurate for cardiovascular, malate for energy. Total elemental magnesium across all sources should fall in the 400-800 mg range daily, split across meals to minimize GI effect, with upper end reserved for users with documented deficiency or clinical indication.
Cost at advanced level: approximately $60-120 per month for the magnesium components alone (threonate is the main cost driver).
Commonly Stacked With
Magnesium stacks favorably with numerous compounds; the question is usually one of timing and avoiding competitive absorption or redundant overlap. Below are the most important stacking considerations ranked by evidential strength and practical relevance.
Vitamin D (reciprocal synergy): This is arguably the single most important stacking relationship in foundational nutrition. Magnesium is required for multiple enzymes in vitamin D metabolism: CYP27B1 (25-hydroxyvitamin D-1-alpha-hydroxylase) that converts 25(OH)D to active 1,25(OH)2D, CYP24A1 (responsible for vitamin D catabolism), and vitamin D-binding protein synthesis (Uwitonze and Razzaque, PMID 29480918). Patients with magnesium deficiency often respond poorly to vitamin D supplementation—serum 25(OH)D may rise but active 1,25(OH)2D remains suboptimal and clinical effects are blunted. Conversely, vitamin D modestly enhances intestinal magnesium absorption. The practical recommendation: any user taking vitamin D 1,000 IU or more daily should also take magnesium (200-400 mg elemental) to ensure vitamin D's activation and physiological effect. See /compound/vitamin-d for detail on the reciprocal relationship.
Zinc: Magnesium and zinc are both commonly deficient, both have broad biological roles, and they do not meaningfully compete for absorption at physiological doses (despite folk wisdom to the contrary). They are often included together in "ZMA" products (zinc 30 mg + magnesium aspartate ~450 mg + vitamin B6), which have been studied primarily in athletes for sleep and recovery. The stack is sensible though the specific ZMA formulation is neither unique nor superior to separate glycinate and zinc picolinate. If taking higher-dose supplemental zinc (50+ mg daily chronically) alongside magnesium, monitor copper status—zinc induces intestinal metallothionein that depletes copper, and magnesium has no bearing on copper balance. See /compound/zinc.
Calcium (competitive at high doses): Calcium and magnesium share some absorption pathways and, at gram-plus doses of calcium, can reduce magnesium absorption. Historical recommendations of 2:1 calcium-to-magnesium ratio are outdated; contemporary nutritional thinking suggests roughly 1:1 is physiologically appropriate. Practical recommendation: if supplementing calcium, take at a different meal from magnesium. Most adults get adequate calcium from diet and do not need to supplement; magnesium is much more commonly insufficient.
Vitamin B6 (pyridoxal-5-phosphate): B6 is a cofactor for magnesium-dependent transaminases and may enhance intracellular magnesium retention. The ZMA formulation includes it partly for this reason. Dose 25-50 mg P5P daily is reasonable for those prioritizing magnesium repletion; higher doses (>100 mg pyridoxine chronically) can cause peripheral neuropathy and should be avoided.
Taurine (cardiovascular synergy): Magnesium and taurine are both cardioprotective and both modulate calcium handling in cardiac and vascular tissue. Magnesium taurate combines both in a single molecule; alternatively, separate supplementation of 200-400 mg Mg glycinate + 2-3 g taurine produces similar benefits. Particularly relevant for users targeting blood pressure, arrhythmia, or heart failure support. See /compound/taurine for the taurine literature.
Glycine (functional synergy): Magnesium glycinate delivers both together—roughly 14% of the molecule is elemental magnesium and 86% is glycine, so 500 mg glycinate supplies ~70 mg elemental Mg plus ~430 mg glycine. For users specifically targeting sleep, a bedtime combination of 3-5 g glycine + 200-400 mg Mg (any form) produces additive sedative and relaxation effects. See /compound/glycine.
Melatonin (sleep synergy): Low-dose melatonin (0.3-1 mg) plus magnesium glycinate 200-400 mg at bedtime is a commonly reported effective combination for sleep onset latency and sleep quality, particularly in older adults with age-related melatonin decline. Evidence is largely observational and anecdotal but mechanistically sensible.
Creatine (ATP co-factor): Creatine kinase requires magnesium as the counter-ion for phosphocreatine, and the phospho-transfer reaction uses Mg-ATP. Adequate magnesium status is functionally required for maximal creatine benefit in exercise and cognitive performance. Users taking creatine 3-5 g daily should ensure magnesium is also adequate. See /compound/creatine.
NAD+ precursors (NMN, NR): Multiple sirtuin and PARP reactions are magnesium-dependent; adequate magnesium supports the downstream utilization of NAD+. No specific interaction requires timing, but users investing in expensive NAD+ precursors should ensure foundational minerals are also addressed. See /compound/nmn.
Rapamycin: No specific interaction. Users on rapamycin for longevity purposes should not change magnesium dosing on that account. See /compound/rapamycin.
Metformin: Metformin does not cause magnesium depletion per se, but type 2 diabetes patients (the primary metformin users) have high baseline rates of hypomagnesemia, and magnesium repletion modestly improves insulin sensitivity independent of metformin. Separately, metformin should be taken with meals and magnesium can be taken at any timing; no chelation concern. See /compound/metformin.
L-threonate with other magnesium forms: Users targeting cognitive benefits often take magnesium L-threonate (Magtein) 1,500-2,000 mg of the compound daily split AM/PM, which supplies only ~144-200 mg elemental. To achieve total repletion, pair with magnesium glycinate 200-300 mg elemental at a different time of day (typically bedtime). Total elemental magnesium across the stack should fall in the 300-500 mg range for most adults.
Stacks to avoid:
- High-dose calcium carbonate (>1 g elemental daily) taken with magnesium: reduces both minerals' absorption. Separate.
- Iron supplements with magnesium: mild competitive absorption; separate by 2 hours when possible.
- Tetracyclines, fluoroquinolones, bisphosphonates, levothyroxine with magnesium: chelation or absorption reduction. Separate per the drug interaction guidance above.
Beverage considerations: Alcohol markedly increases urinary magnesium loss; chronic drinkers have markedly higher deficiency rates. Caffeine has a mild magnesium-wasting effect; users with high caffeine intake should ensure repletion.
Food synergy: Dietary magnesium is best absorbed from dark leafy greens, nuts and seeds (pumpkin seeds are particularly dense), whole grains, legumes, and dark chocolate. Users optimizing magnesium should include these foods regularly—a 200 mg supplement plus dietary awareness usually achieves better total-body repletion than a 400 mg supplement with a processed-food diet.
In summary, magnesium is a cornerstone that virtually every other protocol benefits from. The two highest-priority stack partners are vitamin D (functional reciprocity) and zinc (shared deficiency patterns); beyond that, magnesium integrates into essentially any protocol without friction.
Side Effects & Safety
Contraindications
**Absolute contraindications:** - **Myasthenia gravis**: magnesium can worsen neuromuscular weakness by further reducing acetylcholine release at the neuromuscular junction. Patients with myasthenia should avoid supplemental magnesium and should flag any magnesium exposure to their neurologist. Parenteral magnesium in particular is dangerous and is often listed as contraindicated. - **Severe chronic kidney disease (eGFR <30 mL/min/1.73m²) or end-stage renal disease**: impaired renal clearance leads to accumulation; hypermagnesemia can develop insidiously. These patients should only receive magnesium under nephrologist supervision with monitoring. - **Bradyarrhythmia or high-grade AV block without pacemaker**: magnesium slows AV conduction; in patients with baseline conduction abnormalities, pharmacologic doses can precipitate symptomatic bradycardia or heart block. - **Hypermagnesemia of any cause**: no supplementation while hypermagnesemic. **Relative contraindications / caution:** - **Moderate chronic kidney disease (eGFR 30-59 mL/min/1.73m²)**: supplement only with monitoring. Many guidelines suggest total elemental magnesium ≤200 mg/day with periodic serum level checks. - **Bowel obstruction or severe ileus**: oral magnesium can worsen symptoms and risk hypermagnesemia from stagnant absorption. - **Concurrent use of magnesium-containing laxatives or antacids**: additive dosing can exceed typical ranges; add up the total daily elemental load. - **Patients on digoxin**: magnesium affects digoxin pharmacodynamics at the Na-K-ATPase; hypomagnesemia worsens digoxin toxicity, but concurrent high-dose oral magnesium should be managed with knowledge of digoxin levels. - **Patients on calcium channel blockers, beta-blockers, or antiarrhythmics**: additive effects on cardiac conduction at pharmacologic magnesium doses; ambulatory supplementation at 400-500 mg is typically fine, but IV magnesium requires caution. - **Neuromuscular blocking agents (peri-surgical)**: magnesium potentiates neuromuscular blockade; relevant for anesthesia teams rather than routine users. - **Pre-existing gastrointestinal disease (IBD, short bowel syndrome)**: dose-limiting GI effects more pronounced; favor glycinate and start low. **Drug interactions warranting timing separation:** - Fluoroquinolone antibiotics (cipro, levo, moxifloxacin): separate by ≥2 hours - Tetracycline antibiotics (doxycycline, minocycline, tetracycline): separate by ≥2 hours - Bisphosphonates (alendronate, risedronate, ibandronate): separate by ≥2 hours - Levothyroxine: separate by ≥4 hours - Gabapentin: separate by ≥2 hours - Iron supplements: separate by ≥2 hours **Drug interactions affecting magnesium status (these medications deplete magnesium):** - Chronic proton pump inhibitors (omeprazole, lansoprazole, pantoprazole, esomeprazole, dexlansoprazole): FDA black-box warning for hypomagnesemia with chronic use. Users on long-term PPI should supplement or monitor. - Loop diuretics (furosemide, bumetanide, torsemide) - Thiazide diuretics (hydrochlorothiazide, chlorthalidone, indapamide) — chronic use - Digoxin (both directions: digoxin can increase magnesium loss, and low magnesium worsens digoxin toxicity) - Cisplatin chemotherapy - Cyclosporine, tacrolimus - Amphotericin B - Foscarnet - Pentamidine **Populations requiring clinician input before supplementation:** - Pregnancy: generally safe within RDA + UL range (up to 350-400 mg elemental from supplements), but high-risk pregnancy or preeclampsia should be managed by obstetric team. - Breastfeeding: safe within RDA range. - Infants and young children: pediatric dosing is age-based; do not apply adult doses. - Elderly with polypharmacy: screen for drug interactions and renal function before initiating. - Post-bariatric surgery: absorption may be altered; monitor. - Patients with cardiac arrhythmia history: coordinate with cardiology. **Overdose and emergency:** - Symptoms of hypermagnesemia: nausea, flushing, hyporeflexia, hypotension, bradycardia, respiratory depression, cardiac arrest (at extreme levels). - Emergency treatment: IV calcium gluconate as functional antagonist; dialysis if severe and CKD-related; supportive care. - Call poison control (1-800-222-1222 in US) for any acute ingestion of more than 10 g of elemental magnesium, particularly in children, elderly, or impaired renal function. **Pediatric specific:** - Magnesium-containing laxatives should be avoided in infants under age 2 unless specifically directed by pediatrician; cases of hypermagnesemia in small children from standard-appearing adult-dose products are reported. - Pediatric supplementation doses: follow age-based RDA (30 mg elemental for 0-6 months, scaling up). **Pre-operative considerations:** - Disclose magnesium supplementation to anesthesia team; high-dose oral magnesium or recent IV magnesium potentiates neuromuscular blocking agents. - Routine oral magnesium at 200-400 mg does not require discontinuation but should be noted. In practical terms, for a healthy adult with normal renal function taking a well-tolerated form at reasonable dose, magnesium is among the safest supplements available. The contraindications above are important but narrow; most users can safely take 200-500 mg elemental daily indefinitely without concern.
Additional Notes
Elemental magnesium content by form (approximate, per 100 mg of compound):
- Magnesium oxide: 60 mg elemental (high %, but poorly absorbed; effective absorbed dose is lower than elemental mass implies)
- Magnesium chloride: 12 mg elemental
- Magnesium citrate: 16 mg elemental
- Magnesium glycinate (bisglycinate): 14 mg elemental
- Magnesium L-threonate: 8 mg elemental
- Magnesium malate: 10-15 mg elemental depending on stoichiometry
- Magnesium taurate: 9 mg elemental
- Magnesium sulfate (Epsom salt): 10 mg elemental
- Magnesium orotate: 7 mg elemental
Supplement label interpretation: Always read the Supplement Facts panel for elemental magnesium content—some products list only the weight of the compound, which substantially overstates effective dose. A 1,000 mg "magnesium glycinate" capsule typically supplies ~140 mg elemental. A 1,500 mg "Magtein" capsule supplies ~144 mg elemental.
Target total daily elemental magnesium intake:
- Recommended Dietary Allowance (RDA, adult): 310-320 mg women, 400-420 mg men (lower end of adequacy; most researchers view these as minimums rather than optima)
- Reasonable supplementation target for most adults: 200-400 mg elemental from supplements, assuming diet provides 200-300 mg additional
- Upper tolerable intake from supplements (UL per National Academies): 350 mg elemental/day—but this reflects the GI tolerability threshold, not a toxicity threshold, and is routinely exceeded without harm in adults with normal renal function
- Clinical indication dosing (migraine, hypertension, T2D): 400-600 mg elemental daily
Timing considerations:
- Evening/bedtime: glycinate, L-threonate (PM portion), taurate. Leverages sedating/relaxing effects for sleep.
- Morning or spread across day: citrate, chloride, malate. Favored when GI transit effect is welcome or neutral.
- With meals: all forms absorb slightly better with food; not strictly required.
- Split dosing: for doses >400 mg elemental, split to AM + PM to minimize any GI effect and maintain steady absorption.
Time to effect:
- Acute (hours to days): bowel regularity, relaxation, reduced muscle twitching, improved sleep onset
- Subacute (1-4 weeks): sleep quality improvement, reduced anxiety, reduced migraine frequency onset, blood pressure changes emerging
- Steady-state (4-12 weeks): full migraine prophylaxis effect, glycemic improvements, cognitive effects (with threonate)
- Long-term (months): bone mineral density changes, cardiovascular risk reduction (by inference from observational data)
Dose adjustment guidance:
- If developing loose stool: reduce dose by 25-50%, or switch from oxide/citrate to glycinate, or split dosing. Diarrhea is not a sign of toxicity—just intolerance.
- If no subjective effect after 6-8 weeks at 400 mg elemental: verify form (oxide products are often culprit); verify timing; consider RBC magnesium measurement; consider other causes for the target symptom.
- If unusually sedated or dizzy on initial doses: reduce; take with evening meal rather than empty stomach.
Cycling: Not required. Magnesium supplementation can be taken indefinitely.
Measurement:
- Serum magnesium (routine chem panel): reference range typically 1.7-2.2 mg/dL (0.7-0.9 mmol/L). Insensitive for total-body status; normal serum does not rule out deficiency.
- Red blood cell (RBC) magnesium: better reflects cellular stores; reference typically 4.2-6.8 mg/dL. Available at specialty labs.
- Ionized serum magnesium: research use; not routinely available.
- 24-hour urinary magnesium: can detect renal wasting.
- Magnesium loading test: administer IV Mg, measure 24-hr urinary retention; research-grade measure of total-body status.
Most users do not need baseline testing to begin supplementation; the safety margin is wide and the prior probability of deficiency is high. Testing is warranted if the clinical question is whether to escalate beyond standard doses or if cardiovascular/arrhythmia concerns are present.
When to consider pharmacologic supplementation versus OTC supplements: OTC supplements at 200-500 mg elemental daily are appropriate for repletion and general benefit. Prescription magnesium (e.g., MagNeoGel, SlowMag) offers no meaningful advantage over good OTC glycinate at matched elemental dose. IV magnesium is reserved for defined medical indications.
Frequently Asked Questions
What is the recommended Magnesium dosage?
Dosage for Magnesium varies by protocol. Consult a qualified healthcare provider.
How often should I take Magnesium?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Magnesium need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Magnesium side effects?
Oral magnesium supplementation is among the safest nutrient interventions in clinical medicine for adults with normal renal function. The primary dose-limiting side effect is osmotic diarrhea, which is form-dependent and dose-dependent. Magnesium oxide produces diarrhea at lowest threshold (often 300-400 mg elemental), followed by magnesium citrate (occasional loose stool at 400-500 mg, definite at 600-800 mg), while magnesium glycinate, taurate, and L-threonate are generally well-tolerated even at 500-800 mg elemental. This is not a toxicity per se—healthy gut handles the osmotic load without systemic consequence—but is the dose ceiling for most users and a reason to choose a form matched to the goal (glycinate for nightly sleep or cognitive use; citrate when mild laxative effect is welcome; oxide only when cost is the dominant concern). **Severe dose-limiting effects of oral magnesium:** - Diarrhea, loose stools, abdominal cramping (most common, dose- and form-dependent) - Nausea - Rarely, vomiting at very high single doses - Abdominal bloating or flatulence (more common with citrate or oxide) **Magnesium toxicity (hypermagnesemia)** is essentially unseen in adults with normal renal function taking oral supplements, because intestinal absorption is self-limiting (higher luminal Mg reduces fractional absorption) and renal excretion efficiently clears any systemic excess. Clinically significant hypermagnesemia arises almost exclusively in three scenarios: 1. **Chronic kidney disease** (eGFR <30 mL/min), where renal clearance is impaired. These patients should not take magnesium supplements except under nephrologist supervision. 2. **Acute ingestion of gram-level doses** of magnesium-containing laxatives or antacids, especially in elderly or dehydrated individuals with reduced renal reserve. Hospital case reports describe this after large Epsom salt or magnesium citrate laxative ingestion. 3. **Intravenous magnesium administration** (preeclampsia, torsades) where rate and total load exceed renal clearance—monitored with deep tendon reflexes and serum levels in medical settings. Symptoms of clinically significant hypermagnesemia progress with serum level: mild (3-5 mg/dL): nausea, flushing, headache; moderate (5-7 mg/dL): hyporeflexia, hypotension, bradycardia; severe (>7 mg/dL): respiratory depression, cardiac arrest. Treatment is IV calcium gluconate plus dialysis if severe. **Specific form-related considerations:** - **Magnesium oxide**: low bioavailability, high diarrhea rate, cheapest. Appropriate primarily for constipation relief or when cost is the only consideration. Not recommended for repletion-focused use. - **Magnesium citrate**: moderate bioavailability, moderate GI effect (mild laxative at higher doses, which many users find welcome). Inexpensive. Good default for general repletion. - **Magnesium glycinate/bisglycinate**: high bioavailability, minimal GI effect, mildly sedating via glycine (favorable for sleep use). Most common form for larger doses or evening use. More expensive per mg elemental. - **Magnesium L-threonate (Magtein)**: high bioavailability, unique claim of brain penetration, typically packaged at 1,500-2,000 mg of the compound delivering approximately 144-200 mg elemental. Most expensive. Used specifically for cognitive goals, often alongside glycinate for total repletion. - **Magnesium taurate**: moderate bioavailability, combines magnesium with taurine (both cardioprotective). Favored for cardiovascular indications. Moderately priced. - **Magnesium malate**: moderate bioavailability, supplies malate which enters the TCA cycle. Sometimes favored for fibromyalgia and fatigue, though evidence is thin. Moderately priced. - **Magnesium chloride**: high bioavailability, decent GI tolerability, notably bitter taste in liquid form. Appropriate for repletion. - **Magnesium sulfate (Epsom salt)**: primarily used orally as a short-term laxative or transdermally (bath salts—though transdermal magnesium absorption is debated, with limited evidence that Epsom baths meaningfully raise systemic magnesium). - **Magnesium orotate**: moderate bioavailability, small evidence base in heart failure (Stepura and Martynow). Expensive. - **Magnesium aspartate**: high bioavailability, but aspartate can be excitotoxic at high doses. Not a preferred form. **Drug interactions:** Magnesium can chelate certain oral medications, reducing absorption. Clinically relevant: - **Fluoroquinolone antibiotics** (ciprofloxacin, levofloxacin): separate by at least 2 hours - **Tetracycline antibiotics** (doxycycline, minocycline): separate by at least 2 hours - **Bisphosphonates** (alendronate, risedronate): separate by at least 2 hours - **Levothyroxine**: separate by at least 4 hours (magnesium reduces thyroxine absorption) - **Gabapentin**: magnesium may reduce absorption; separate by 2 hours **Medications that increase magnesium loss:** proton pump inhibitors (chronic PPI use is a well-established cause of hypomagnesemia per FDA black-box warning), loop diuretics (furosemide, bumetanide), thiazide diuretics (chronic use), digoxin, certain chemotherapy agents (cisplatin), calcineurin inhibitors (cyclosporine, tacrolimus). Patients on any of these should consider routine supplementation. **Pregnancy and lactation:** Magnesium is safe and often beneficial in pregnancy (nocturnal leg cramps, preeclampsia risk reduction suggested by observational data). Oral doses up to 350-400 mg elemental are within the RDA + UL range. Intravenous magnesium is standard-of-care for severe preeclampsia/eclampsia. **Infants and children:** Pediatric dosing follows age-based RDA; clinical pharmacists should supervise any supplementation. Avoid magnesium-containing laxatives in young children unless directed. In summary, for the large majority of adults without renal disease, magnesium supplementation in reasonable doses (200-500 mg elemental daily from well-tolerated forms) is among the safest high-impact interventions available.
Where can I buy Magnesium?
Visit our vendor directory to find trusted sources for Magnesium.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
